Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
3.200
-0.080 (-2.44%)
At close: Aug 21, 2026, 4:00 PM EDT
3.260
+0.060 (1.87%)
After-hours: Aug 21, 2026, 7:48 PM EDT
Decoy Therapeutics Employees
Decoy Therapeutics had 11 employees as of December 31, 2025. The number of employees increased by 9 or 450.00% compared to the previous year.
Employees
11
Change (1Y)
9
Growth (1Y)
450.00%
Revenue / Employee
$20,694
Profits / Employee
-$1,313,595
Market Cap
2.10M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 11 | 9 | 450.00% | 11 | 0 |
| Dec 31, 2024 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2023 | 2 | -10 | -83.33% | 2 | 0 |
| Dec 31, 2022 | 12 | -4 | -25.00% | 12 | 0 |
| Dec 31, 2021 | 16 | 7 | 77.78% | 16 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| Virax Biolabs Group | 26 |
| Silexion Therapeutics | 14 |
| CDT Equity | 4 |
| Oragenics | 3 |
| 60 Degrees Pharmaceuticals | 3 |
| Propanc Biopharma | 2 |
| Bone Biologics | 2 |
DCOY News
- 11 days ago - Decoy Therapeutics Quarterly report: Q2 2026 - Filings
- 19 days ago - Decoy Therapeutics Proxy statement: Proxy filing - Filings
- 19 days ago - Decoy Therapeutics Proxy statement: Proxy filing - Filings
- 20 days ago - Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform - PRNewsWire
- 27 days ago - Decoy Therapeutics’ D-MAV platform shows inhibition of Ebola Zaire virus - TheFly
- 27 days ago - Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV™ Platform into High Consequence Global Health Threats - PRNewsWire
- 4 weeks ago - Decoy Therapeutics Proxy statement: Proxy filing - Filings
- 5 weeks ago - Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors - PRNewsWire